Genomatica

Executive Summary

Genomatica is a synthetic biology company leading the transition to sustainable chemicals by engineering microorganisms to produce renewable alternatives to fossil fuel-derived materials. Its proprietary platform enables the fermentation of plant-based feedstocks into key chemical building blocks like 1,4-butanediol (BDO) and caprolactam, used in apparel, personal care, and performance materials. With commercial-scale production already demonstrated, Genomatica has secured partnerships with major brands such as Lululemon and Unilever to decarbonize supply chains. The company's technology reduces carbon emissions by over 90% compared to petrochemical processes, addressing growing regulatory and consumer demand for eco-friendly products. As of 2026, Genomatica is expanding its molecule pipeline and production capacity, positioning itself as a key enabler of the bioeconomy. With its proven track record, strong IP portfolio, and strategic alliances, Genomatica is poised for significant growth as industries accelerate their sustainability commitments.

Upcoming Catalysts (preview)

• Q4 2026Commercial launch of bio-based caprolactam for nylon production70% success
• Q2 2026Expansion of partnership with Lululemon or similar brand for bio-BDO in apparel80% success
• Q3 2026IPO filing or major funding round (Series F or later)60% success